Immunosuppressive therapy improves pancytopenia in severe aplastic anemia.However, its effects are not long-lasting as evidenced by a modest 2-year EFS rate of just 46%, prompting the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback